News

Filter

Current filters:

None

Popular Filters

1 to 25 of 8476 results

Celgene gains rights to Nogra product in potential $1 billion-plus deal

Celgene gains rights to Nogra product in potential $1 billion-plus deal

24-04-2014

US biotech firm Celgene has entered a global license agreement with privately-held Irish company Nogra…

Anti-Arthritics/RheumaticsBiotechnologyCelgeneGED-0301LicensingNogra Pharma

Actavis settles Celebrex patent challenge with Pfizer

24-04-2014

Ireland-headquartered generic major Actavis has entered into an agreement with US pharma giant Pfizer…

ActavisAnti-Arthritics/RheumaticsCelebrexGenericsLegalPatentsPfizerUSA

Celgene beats expectations, despite profit downturn

24-04-2014

US biotech firm Celgene saw its shares fall 3.3% to $140.05 in mid-morning trading after it posted first-quarter…

BiotechnologyCelgeneFinancial

Marken ready for orphan drug distribution

24-04-2014

USA-based Marken, a global clinical supply chain solutions provider, has released a new white paper which…

Markets & MarketingPharmaceuticalProductionRare diseases

WuXi PharmaTech announces Management Appointments

WuXi PharmaTech announces Management Appointments

24-04-2014

China’s WuXi PharmaTech (NYSE: WX) has announced that Dr Steve Yang has joined the company as Executive…

BiotechnologyBoardroomChinaPharmaceuticalWuXi PharmaTech

AstraZeneca first quarter sales flat, but beat forecasts

24-04-2014

Anglo-Swedish drug major AstraZeneca this morning posted first-quarter 2014 financials, revealed sales…

AstraZenecaFinancialPharmaceutical

Eli Lilly 1st-qtr 2014 net income plunges, sales down, hit by generic competition

24-04-2014

US pharma major Eli Lilly posted first-quarter 2014 financial results, with revenue declined 16 % to…

Eli LillyFinancialPharmaceutical

Hyperion Therapeutics to broaden orphan disease pipeline with buy of Israeli firm

24-04-2014

US biotech firm Hyperion Therapeutics has entered into a definitive agreement to acquire Andromeda Biotech,…

Andromeda BiotechBiotechnologyDiabetesDiaPep277Hyperion TherapeuticsMergers & Acquisitions

Merck releases positive Ph IIIb results for Kuvan

24-04-2014

German pharma and life sciences major Merck KGaA announced today that the Phase IIIb SPARK study with…

KuvanMerck KGaAPharmaceuticalRare diseasesResearch

CT Catapult to work with Athersys to advance European development of MultiStem therapy

24-04-2014

The Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase…

AthersysBiotechnologyCell Therapy CatapultEuropeMarkets & MarketingResearch

Impax Laboratories appoints Frederick Wilkinson as President and CEO

Impax Laboratories appoints Frederick Wilkinson as President and CEO

24-04-2014

US generic drugmaker Impax Laboratories (NASDAQ: IPXL) has announced the appointment of Frederick Wilkinson…

BiotechnologyBoardroomImpax LaboratoriesPharmaceuticalUSA

FDA backs Janssen’s Sylvant for rare disease

24-04-2014

The US Food and Drug Administration yesterday approved Johnson & Johnson subsidiary Janssen Biotech’s…

Janssen BiotechJohnson & JohnsonNorth AmericaOncologyPharmaceuticalRare diseasesRegulationsiltuximabSylvantUSA

Novartis 1st-qtr net profit flat, sales shy of forecasts

Novartis 1st-qtr net profit flat, sales shy of forecasts

24-04-2014

Swiss drug major Novartis posted a solid set of first-quarter 2014 financials this morning, showing that…

AlconFinancialNovartisPharmaceuticalSandoz

Lupin inks strategic biosimilars joint venture agreement with Yoshindo

23-04-2014

Indian drugmaker Lupin has entered into a strategic joint venture agreement with Japanese pharma company,…

BiosimilarsBiotechnologyEnbrelInflammatory diseasesJapanLicensingLupinTakeda PharmaceuticalYoshindo

Biogen Idec 1st-qtr 2014 revenue leaps 51%, driven by Tecfidera and MS franchise

23-04-2014

US biotech firm Biogen Idec first-quarter 2014 results today, including revenue of $2.1 billion, a 51%…

Biogen IdecBiotechnologyFinancialNeurologicalResearchTecfidera

IQWiG finds added benefit for Novo Nordisk’s NovoEight not proven

23-04-2014

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

GermanyHematologyNorthern EuropeNovo NordiskNovoEightPharmaceuticalPricingRegulation

Abbott may acquire one of Russia’s leading drugmakers for $240 million

23-04-2014

The USA’s Abbott Laboratories is considering acquiring the 81.1 % stake in Veropharm, one of Russia’s…

Abbott LaboratoriesGenericsMergers & AcquisitionsRussiaVeropharm

Allergan adopts stockholder rights plan

23-04-2014

USA-based Allergan, the subject of a hostile takeover bid from Canada’s Valeant Pharmaceuticals reported…

AllerganFinancialMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Amgen's 1st-qtr 2014 disappoints, as net income falls 25%

23-04-2014

Amgen, the world’s largest independent biotech firm by revenues, yesterday announced financial results…

AmgenBiotechnologyFinancialResearch

Bristol-Myers Squibb and Samsung BioLogics expand manufacturing deal

23-04-2014

US drug major Bristol-Myers Squibb and South Korea’s Samsung BioLogics revealed that they will increase…

Asia-PacificBiotechnologyBristol-Myers SquibbProductionSamsung BioLogics

Pharmaceutical CPI growth due to Australian government policy

23-04-2014

The Australian Consumer Price Index (CPI) for the March quarter has shown growth in pharmaceutical prices…

Asia-PacificAustraliaPharmaceuticalPoliticsPricing

Health care M&A activity in 1st-qtr 2014 softens compared with 4th-qtr 2013; report

23-04-2014

Health care merger and acquisition activity was a little soft in the first quarter of 2014. Deal volume…

Mergers & AcquisitionsPharmaceutical

Number of clinical trials in Russia declined in 2013

23-04-2014

The number of clinical trials taking place in Russia in 2013 amounted 791, which is 13.6% lower than…

Eastern EuropePharmaceuticalResearchRussia

1 to 25 of 8476 results

Back to top